

World Health Organization
The World Health Organization (WHO) is a specialized UN agency dedicated to promoting global health. It coordinates international health responses, develops policies, supports health systems, combats diseases, sets health standards, conducts research, and disseminates information to improve health outcomes worldwide.
Meet Your President

Santiago Tovar
Santiago Tovar
President, World Health Organization
Greetings, esteemed delegates.
As your president, Santiago Tovar, I have the pleasure of welcoming you to this important World Health Organization committee. We have gathered to address one of the biggest and most complex problems of our time: the global regulation of CRISPR gene-editing technology.
​
The future of agriculture, human health, and our physical environment are all affected by the policy we are discussing today. The task at hand is not fictitious. The entire world is looking for a logical, moral, and equitable framework to direct its utilization as this field's advancements pick up speed. It is your duty to serve as that framework for the betterment of humanity for the next centuries.
​
I invite you to take advantage of this moment's potential and seriousness. Go beyond positions that are ready. Employ polite, substantive diplomacy. And most importantly pay close attention to viewpoints that are distinct from your own and look for mutually beneficial solutions that achieve a balance between progress and justice, safety and creativity. In BAMUN XXV, you hone your critical thinking, consensus-building, and negotiation skills, the very skills to be leaders of tomorrow and leave a mark.
​
I am open to any questions!! My gmail is tovar.santiago@marymountbq.edu.co
Let's commence our job by committing to participate in enthusiastic, morally upright discussions. This session is now in order.
​
Cordially
​
Santiago Tovar​
President World Health Organization
CRISPR and Global Health: Towards Ethical Governance and Gene Editing
Committee Topic
As biotechnology advances at an unprecedented pace, the emergence of CRISPR gene-editing technology has revolutionized medicine, offering potential cures for genetic disorders and breakthroughs in global health. However, this innovation also raises profound ethical, social, and safety concerns. The lack of universal regulation and oversight risks misuse, inequality in access, and unintended genetic consequences. The World Health Organization is convening to address these challenges and establish frameworks for responsible governance of gene editing. Delegates must balance scientific progress with ethical responsibility, ensuring that CRISPR technology is used to promote health equity, protect human rights, and uphold the integrity of medical research worldwide.